Bjørn Fuglaas
Vorsitzender bei Norwegian Bioindustry Association
Profil
Bjørn Fuglaas is currently the Chairman of Norwegian Bioindustry Association, CardiNor AS, Norwegian University of Science & Technology, Legemiddelindustrien, Pharmaceutical Industry Association of South Africa, and Oxy Solutions AS.
He previously worked as the Managing Director & Director of GE Healthcare AS and as a Director of Bionor Pharma ASA.
Aktive Positionen von Bjørn Fuglaas
| Unternehmen | Position | Beginn |
|---|---|---|
| Norwegian Bioindustry Association | Vorsitzender | - |
Legemiddelindustrien
 Legemiddelindustrien Pharmaceuticals: MajorHealth Technology Legemiddelindustrien provides pharmaceutical industry services. The private company is based in Oslo, Norway. | Direktor/Vorstandsmitglied | - |
| Norwegian University of Science & Technology | Direktor/Vorstandsmitglied | - |
| Pharmaceutical Industry Association of South Africa | Direktor/Vorstandsmitglied | - |
Oxy Solutions AS
 Oxy Solutions AS Miscellaneous Commercial ServicesCommercial Services Oxy Solutions AS engages in the research and development of products in the areas of vitro cell models, methods for assessing protein expression in different cell types, skin wound healing assays, still and live imaging, measure expression, and location of proteins within cells. It offers products to a wide range of markets including biomedical production, beverage, cosmetics and wound healing, medical applications, and fish farming. The company was founded on July 7, 2010 and is headquartered in Oslo, Norway. | Direktor/Vorstandsmitglied | - |
CardiNor AS
 CardiNor AS BiotechnologyHealth Technology CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway. | Vorsitzender | - |
Ehemalige bekannte Positionen von Bjørn Fuglaas
| Unternehmen | Position | Ende |
|---|---|---|
GE Healthcare AS
 GE Healthcare AS Medical SpecialtiesHealth Technology GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway. | Vorstandsvorsitzender | - |
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
GE Healthcare AS
GE Healthcare AS Medical SpecialtiesHealth Technology GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway. | Health Technology |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
| Norwegian Bioindustry Association | |
Legemiddelindustrien
Legemiddelindustrien Pharmaceuticals: MajorHealth Technology Legemiddelindustrien provides pharmaceutical industry services. The private company is based in Oslo, Norway. | Health Technology |
| Pharmaceutical Industry Association of South Africa | |
CardiNor AS
CardiNor AS BiotechnologyHealth Technology CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway. | Health Technology |
Oxy Solutions AS
Oxy Solutions AS Miscellaneous Commercial ServicesCommercial Services Oxy Solutions AS engages in the research and development of products in the areas of vitro cell models, methods for assessing protein expression in different cell types, skin wound healing assays, still and live imaging, measure expression, and location of proteins within cells. It offers products to a wide range of markets including biomedical production, beverage, cosmetics and wound healing, medical applications, and fish farming. The company was founded on July 7, 2010 and is headquartered in Oslo, Norway. | Commercial Services |
